Pub. Date : 2010 Feb 10
PMID : 20065189
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | This open-label, phase II study assessed the efficacy of vandetanib, a selective oral inhibitor of RET, vascular endothelial growth factor receptor, and epidermal growth factor receptor signaling, in patients with advanced hereditary MTC. | vandetanib | epidermal growth factor receptor | Homo sapiens |